Fig. 1

The rationale for the design of substituted piperazine conjugated to quinoline-thiosemicarbazide as new α-glucosidase inhibitors
The rationale for the design of substituted piperazine conjugated to quinoline-thiosemicarbazide as new α-glucosidase inhibitors